Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1999 Sep;83(9):1069–1073. doi: 10.1136/bjo.83.9.1069

α/β− and γ/δ TCR+ lymphocyte infiltration in necrotising choroidal melanomas

A Bialasiewicz 1, J Ma 1, G Richard 1
PMCID: PMC1723174  PMID: 10460778

Abstract

AIM—To detect specific tumour infiltrating T cells (TIL) carrying antigen specific MHC-I restricted receptor genes on necrotising and non-necrotising malignant melanomas and to correlate the findings with clinical data.
METHODS—α/β− and γ/δ− TIL were determined by immunohistochemical staining in melanomas of patients with known follow up of more than 10 years. An antigen retrieval method was used to determine variable genes δ1 and γ1 on TCR+ cells by an anti-TCR Vδ1 and anti-CrγM1, and of Vα and Vβ TCR+ by an anti-pan-TCR+ α/β antibody.
RESULTS—Intratumoral TIL were present in 86 of 113 (76.1%) necrotising melanomas (NMM) v 21 of 100 (21%) in non-necrotising melanomas (MM); of these, Vα/β− TCR+ cells were present in 52 of 74 (70.3%) TIL harbouring NMM v four of 21 (19%) MM; Vγ1 in 29 of 74 (39.2%) NMM v two of 21 (10%) MM; and Vδ1 in 39 of 74 (52.7%) NMM v three of 21 (14%) MM. Extratumoral lymphocytic infiltration was seen in 86 (76.1%) NMM including Vα/β TCR+ cells in 10 (11.6%) cases, v five (5%) MM cases with no Vα/β TCR+ cells detected. Vγ1 and Vδ1 TCR+ cells were not found in extratumoral infiltrates.
CONCLUSIONS—In NMM, the median survival was 69.3 (range 6-237) months, 19 of 74 patients (25.7%) survived 5 years, and mortality was associated with advanced stage (p<0.001), patient age (p<0.023), and extent of necrosis (p<0.048). Survival was increased with evidence of Vγ1 and Vδ1 TCR+ cells (p<0.026).



Full Text

The Full Text of this article is available as a PDF (94.4 KB).

Figure 1  .

Figure 1  

Open in a new tab

Kaplan-Meier plot showing significant negative correlation of tumour stage and patient survival (p<0.001).

Figure 2  .

Figure 2  

Open in a new tab

Kaplan-Meier plot showing significant negative correlation of patient age and patient survival (p=0.023).

Figure 3  .

Figure 3  

Open in a new tab

Kaplan-Meier plot showing significant positive correlation of Vγ and Vδ TCR+cell infiltration and patient survival (p=0.026).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chapoval A. I., Nelson H., Thibault C. Anti-CD3 x anti-tumor F(ab')2 bifunctional antibody activates and retargets tumor-infiltrating lymphocytes. J Immunol. 1995 Aug 1;155(3):1296–1303. [PubMed] [Google Scholar]
  2. Cole D. J., Wilson M. C., Rivoltini L., Custer M., Nishimura M. I. T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes. Cancer Res. 1997 Dec 1;57(23):5320–5327. [PubMed] [Google Scholar]
  3. Coleman K., Baak J. P., Van Diest P., Mullaney J., Farrell M., Fenton M. Prognostic factors following enucleation of 111 uveal melanomas. Br J Ophthalmol. 1993 Nov;77(11):688–692. doi: 10.1136/bjo.77.11.688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Davidorf F. H., Lang J. R. Lymphocytic infiltration in choroidal melanoma and its prognostic significance. Trans Ophthalmol Soc U K. 1977 Sep;97(3):394–401. [PubMed] [Google Scholar]
  5. Durie F. H., Campbell A. M., Lee W. R., Damato B. E. Analysis of lymphocytic infiltration in uveal melanoma. Invest Ophthalmol Vis Sci. 1990 Oct;31(10):2106–2110. [PubMed] [Google Scholar]
  6. Faber W., Kock E. Die prognostische Bedeutung histopathologischer Befunde bei malignen Melanomen der Chorioidea und des Ziliarkörpers insbesondere bei regressiven Veränderungen. Klin Monbl Augenheilkd. 1982 Dec;181(6):458–464. doi: 10.1055/s-2008-1055271. [DOI] [PubMed] [Google Scholar]
  7. Grimm D. R., Richerson J. T., Theiss P. M., LeGrand R. D., Misfeldt M. L. Isolation and characterization of gamma delta T lymphocyte cell lines from Sinclair swine peripheral blood. Vet Immunol Immunopathol. 1993 Sep;38(1-2):1–20. doi: 10.1016/0165-2427(93)90110-p. [DOI] [PubMed] [Google Scholar]
  8. Göllnitz R., Lommatzsch P. K. Zur prognostischen Bedeutung der lymphozytären Infiltration beim malignen Melanom der Aderhaut. Klin Monbl Augenheilkd. 1988 Jun;192(6):660–665. doi: 10.1055/s-2008-1050200. [DOI] [PubMed] [Google Scholar]
  9. Haas W., Pereira P., Tonegawa S. Gamma/delta cells. Annu Rev Immunol. 1993;11:637–685. doi: 10.1146/annurev.iy.11.040193.003225. [DOI] [PubMed] [Google Scholar]
  10. Jensen O. A. Malignant melanomas of the human uvea: 25-year follow-up of cases in Denmark, 1943--1952. Acta Ophthalmol (Copenh) 1982 Apr;60(2):161–182. doi: 10.1111/j.1755-3768.1982.tb08371.x. [DOI] [PubMed] [Google Scholar]
  11. Kowalczyk D., Skorupski W., Drews M., Nowak J. Different pattern of T cell receptor delta gene rearrangement in tumour-infiltrating lymphocytes and peripheral blood in patients with solid tumours. Cancer Immunol Immunother. 1994 Oct;39(4):275–278. doi: 10.1007/BF01525992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kremer I., Gilad E., Kahan E., Derazne E., Bar-Ishak R. Necrosis and lymphocytic infiltration in choroidal melanomas. Acta Ophthalmol (Copenh) 1991 Jun;69(3):347–351. doi: 10.1111/j.1755-3768.1991.tb04826.x. [DOI] [PubMed] [Google Scholar]
  13. Ksander B. R., Bando Y., Acevedo J., Streilein J. W. Infiltration and accumulation of precursor cytotoxic T-cells increase with time in progressively growing ocular tumors. Cancer Res. 1991 Jun 15;51(12):3153–3158. [PubMed] [Google Scholar]
  14. Ksander B. R., Rubsamen P. E., Olsen K. R., Cousins S. W., Streilein J. W. Studies of tumor-infiltrating lymphocytes from a human choroidal melanoma. Invest Ophthalmol Vis Sci. 1991 Dec;32(13):3198–3208. [PubMed] [Google Scholar]
  15. Lambert S. R., Char D. H., Howes E., Jr, Crawford J. B., Wells J. Spontaneous regression of a choroidal melanoma. Arch Ophthalmol. 1986 May;104(5):732–734. doi: 10.1001/archopht.1986.01050170122036. [DOI] [PubMed] [Google Scholar]
  16. Meecham W. J., Char D. H., Kaleta-Michaels S. Infiltrating lymphocytes and antigen expression in uveal melanoma. Ophthalmic Res. 1992;24(1):20–26. doi: 10.1159/000267140. [DOI] [PubMed] [Google Scholar]
  17. Raivio I. Uveal melanoma in Finland. An epidemiological, clinical, histological and prognostic study. Acta Ophthalmol Suppl. 1977;(133):1–64. [PubMed] [Google Scholar]
  18. Reese A. B., Archila E. A., Jones I. S., Cooper W. C. Necrosis of malignant melanoma of the choroid. Am J Ophthalmol. 1970 Jan;69(1):91–104. doi: 10.1016/0002-9394(70)91860-x. [DOI] [PubMed] [Google Scholar]
  19. Seddon J. M., Albert D. M., Lavin P. T., Robinson N. A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol. 1983 Dec;101(12):1894–1899. doi: 10.1001/archopht.1983.01040020896012. [DOI] [PubMed] [Google Scholar]
  20. Seddon J. M., Polivogianis L., Hsieh C. C., Albert D. M., Gamel J. W., Gragoudas E. S. Death from uveal melanoma. Number of epithelioid cells and inverse SD of nucleolar area as prognostic factors. Arch Ophthalmol. 1987 Jun;105(6):801–806. doi: 10.1001/archopht.1987.01060060087039. [DOI] [PubMed] [Google Scholar]
  21. Sensi M., Salvi S., Castelli C., Maccalli C., Mazzocchi A., Mortarini R., Nicolini G., Herlyn M., Parmiani G., Anichini A. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone. J Exp Med. 1993 Oct 1;178(4):1231–1246. doi: 10.1084/jem.178.4.1231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Shi S. R., Key M. E., Kalra K. L. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem. 1991 Jun;39(6):741–748. doi: 10.1177/39.6.1709656. [DOI] [PubMed] [Google Scholar]
  23. Sunba M. S., Rahi A. H., Morgan G., Holborow E. J. Lymphoproliferative response as an index of cellular immunity in malignant melanoma of the uvea and its correlation with the histological features of the tumour. Br J Ophthalmol. 1980 Aug;64(8):576–590. doi: 10.1136/bjo.64.8.576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Wang R., Taniguchi M. Limited T cell antigen receptor repertoire in tumor-infiltrating lymphocyte and inhibition of experimental lung metastasis of murine melanoma by anti-TCR antibody. J Immunol. 1995 Feb 15;154(4):1797–1803. [PubMed] [Google Scholar]
  25. Whelchel J. C., Farah S. E., McLean I. W., Burnier M. N. Immunohistochemistry of infiltrating lymphocytes in uveal malignant melanoma. Invest Ophthalmol Vis Sci. 1993 Jul;34(8):2603–2606. [PubMed] [Google Scholar]
  26. Zeuthen J., Birck A., Straten P. T. Analysis of T cell receptor alpha beta variability in tumor-infiltrating lymphocytes in primary and metastatic melanoma. Arch Immunol Ther Exp (Warsz) 1995;43(2):123–133. [PubMed] [Google Scholar]
  27. Zocchi M. R., Ferrarini M., Rugarli C. Selective lysis of the autologous tumor by delta TCS1+ gamma/delta+ tumor-infiltrating lymphocytes from human lung carcinomas. Eur J Immunol. 1990 Dec;20(12):2685–2689. doi: 10.1002/eji.1830201224. [DOI] [PubMed] [Google Scholar]
  28. de la Cruz P. O., Jr, Specht C. S., McLean I. W. Lymphocytic infiltration in uveal malignant melanoma. Cancer. 1990 Jan 1;65(1):112–115. doi: 10.1002/1097-0142(19900101)65:1<112::aid-cncr2820650123>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES